April 27th, 2012 by Eboni Morris
...
(Keep Reading)
March 26th, 2012 by Katie Whittle
BAXTER INTRODUCES 2 mL DILUENT VOLUME FOR ADVATE
Providing Less Volume to Infuse
ADVATE is now available with a 2 mL diluent (sterile water for infusion) volume for dosage strengths ranging from 250 IU to 1700 IU. This represents a reduction ...
(Keep Reading)
March 14th, 2012 by Katie Whittle
URGENT: BIOLOGIC RECALL INFORMATION
Initiated by : Baxter Healthcare
Event Id : 151
Event Date : 03-14-2012
Therapy
Gammagard Liquid 10%
NDC Number
Lot Number
Size
Packaging
Expiration Date
0944-2700-06
LE12LG70AC
20g
vial
11-25-2014
Reason
Baxter Healthcare Corporation is voluntarily recalling lot LE12LG70AC of GAMMAGARD LIQUID, 10%, 20g size, product code 1502797, NDC# 0944-2700-06. This recall is being ...
(Keep Reading)
February 24th, 2012 by Eboni Morris
New rules published jointly by the Departments of Health and Human Services, Labor and Treasury, require health insurers and group health plans to provide concise and comprehensible information about health plan benefits and coverage to the millions of Americans with ...
(Keep Reading)
February 16th, 2012 by Katie Whittle
Pfizer Hemophilia is pleased to announce that the 3000 IU dose of BeneFIX® is now available for hemophilia B patients. BeneFIX is a recombinant coagulation factor IX product indicated for the control, prevention and perioperative management of bleeding episodes in ...
(Keep Reading)
February 7th, 2012 by Katie Whittle
Click here for FDA recall
North American Rescue, LLC Announces A Follow-Up to the Recall of Crickit® Convenience Kits Because of Possible Health Risk Related to Nationwide Recall of Triad Povidone Iodine Prep Pads
Contact:
Consumer
1-888-689-6277, Monday through Friday, 8:00am to 5:00pm (ET)
FOR ...
(Keep Reading)
January 5th, 2012 by Katie Whittle
Link to Baxter's Press Release
BAXTER INITIATES PHASE I CLINICAL TRIAL OF LONGER-ACTING RECOMBINANT FVIII TREATMENT FOR HEMOPHILIA A
Investigational BAX 855 is based on ADVATE Factor VIII Molecule
DEERFIELD, Ill., January 5, 2012 – Baxter International Inc. today announced the dosing of ...
(Keep Reading)
December 19th, 2011 by Katie Whittle
Direct link to Press Release
ADVATE for routine prophylaxis reduced annual bleed events in hemophilia A patients from forty-four to one as compared to an on-demand regimen in a clinical study
Once every third day pharmacokinetic dosing option offers some patients
the opportunity ...
(Keep Reading)
November 17th, 2011 by Katie Whittle
Link to NHF's Medical Advisory
November 16, 2011
Baxter Healthcare Corporation has sent a notice of a labeling error affecting the expiration date of the Sterile Water for Injection that is packaged as a diluent with RECOMBINATE . The Sterile Water for ...
(Keep Reading)
October 28th, 2011 by Eboni Morris
By Anna Edney
Courtesy of Bloomberg News
Oct. 26 (Bloomberg) -- Two Chinese companies implicated in supplying contaminated ingredients three years ago to Baxter International Inc. for its blood thinner heparin are still supplying product to the U.S., Republican lawmakers said.
Baxter recalled ...
(Keep Reading)
